Related Experiment Video
Updated: Apr 24, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
LINC01128 Affects Triple-Negative Breast Cancer Progression Through Targeting miR-32-5p
Min Xiong1, Quanjun Yang1, Le Cheng1
1Department of Oncology, Affiliated Renhe Hospital of China Three Gorges University, Yichang, Hubei, 443000, People's Republic of China.
Objective:
To clarify the expression and clinical significance of LINC01128 in triple-negative breast cancer (TNBC), investigate whether it regulates the biological behaviors of TNBC cells by targeting miR-32-5p via the ceRNA mechanism, and explore new therapeutic targets.
Methods:
Tumor tissues and corresponding adjacent normal tissues from 76 TNBC patients were collected, and the patients' clinicopathological data were gathered. Experiments were conducted using the human normal breast epithelial cell line MCF-12F and multiple TNBC cell lines. Quantitative real-time PCR (qPCR) was used to detect the relative expressions of LINC01128 and miR-32-5p; dual-luciferase reporter assay was performed to verify the targeted binding relationship between the two. CCK-8 assay, flow cytometry, and Transwell assay were used to detect cell proliferation, apoptosis, and migration abilities, respectively. Target gene prediction and GO/KEGG enrichment analyses were carried out by combining databases such as miRDB and miRWalk.
Results:
LINC01128 was highly expressed in TNBC tissues and cells (P<0.01), and its high expression was an independent risk factor for advanced TNBC (OR=6.635, P=0.001). miR-32-5p was lowly expressed in TNBC (P<0.01) and showed a significant negative correlation with LINC01128 (r=-0.699, P<0.001), with a direct targeted binding between the two. LINC01128 promoted TNBC cell proliferation and migration and inhibited apoptosis by suppressing miR-32-5p (all P<0.01). The target genes of miR-32-5p were enriched in tumor-related pathways.
Conclusion:
LINC01128 is highly expressed in TNBC and promotes tumor progression by targeting and suppressing miR-32-5p via the ceRNA mechanism, which can serve as a potential molecular marker and therapeutic target for TNBC.
Insights
Long non-coding RNA LINC01128 is highly expressed in triple-negative breast cancer (TNBC) and promotes tumor progression by suppressing miR-32-5p. This suggests LINC01128 is a potential therapeutic target for TNBC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Triple-negative breast cancer (TNBC) is an aggressive subtype with limited therapeutic options.
- Long non-coding RNAs (lncRNAs) play crucial roles in cancer development and progression.
- Understanding the molecular mechanisms underlying TNBC is essential for developing novel treatments.
Purpose of the Study:
- To investigate the expression and clinical significance of LINC01128 in TNBC.
- To determine if LINC01128 regulates TNBC cell behaviors by targeting miR-32-5p through the competing endogenous RNA (ceRNA) mechanism.
- To explore LINC01128 as a potential therapeutic target for TNBC.
Main Methods:
- Quantitative real-time PCR (qPCR) to measure LINC01128 and miR-32-5p expression in TNBC tissues and cell lines.
- Dual-luciferase reporter assay to confirm the direct binding between LINC01128 and miR-32-5p.
- Cell proliferation, apoptosis, and migration assays (CCK-8, flow cytometry, Transwell) to assess the functional impact of LINC01128.
- Bioinformatic analyses (miRDB, miRWalk) for target gene prediction and pathway enrichment.
Main Results:
- LINC01128 was significantly upregulated in TNBC tissues and cells compared to normal controls.
- High LINC01128 expression correlated with advanced TNBC and served as an independent risk factor.
- miR-32-5p was downregulated in TNBC and showed a negative correlation with LINC01128.
- LINC01128 promoted TNBC cell proliferation and migration while inhibiting apoptosis by sponging miR-32-5p.
- Target genes of miR-32-5p were enriched in cancer-related pathways.
Conclusions:
- LINC01128 is highly expressed in TNBC and drives tumor progression.
- The LINC01128/miR-32-5p ceRNA axis plays a critical role in regulating TNBC cell behaviors.
- LINC01128 represents a promising molecular marker and therapeutic target for TNBC.
Related Concept Videos
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs

